From 2019 to 2024, the percentage of patients prescribed one of these three GLP-1 drugs increased from .03 to .68 percenta staggering 2,029% increase
While not a substitute for medical evaluation, this data can inform decisions about continued use
Cummings, Department of Biomedical Sciences, Cornell University College of Veterinary Medicine, 930 Campus Road, Ithaca, New York 14853, USA
A peptide company is any commercial entity that synthesizes, manufactures, or distributes peptide compounds, either directly from its own production facilities or through outsourced synthesis with in-house QC and fulfillment
It depends on severity
Provider preference occasionally influences the decision